FDA Adverse Event Injury Summary report: N

FLOWFLEX COVID-19 ANTIGEN HOME TEST

MDR report key: 14325670 · Received May 7, 2022

Report

Report Number
2531491-2022-00007
Event Type
Injury
Date Received
May 7, 2022
Date of Event
March 6, 2022
Report Date
April 28, 2022
Manufacturer
ACON LABORATORIES, INC.
Product Code
QKP
PMA / PMN Number
EUA210494
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

IN THIS FOLLOW-UP REPORT, THE FOLLOWING INFORMATION IS DIFFERENT FROM THE INITIAL REPORT AS NEW INFORMATION REGARDING PATIENT HEALTH WAS RECEIVED. B5: DESRIBE EVENT OR PROBLEM. G7: TYPE OF REPORT. H2: IF FOLLOW-UP, WHAT TYPE? H6: EVENT PROBLEM AND EVALUATION CODES.

Description of Event or Problem · 0

TREATMENT IS TIME SENSITIVE. DEVELOPED SORE THROAT AND COUGH SYMPTOMS. TOOK 2 AT HOME COVID TESTS FROM FLOW FLEX. 24 HOURS APART. FOLLOWED DIRECTIONS, BOTH CAME OUT NEGATIVE, IN SPITE OF FAINTNESS AND FATIGUE SYMPTOMS ON THE SECOND DAY. NEXT DAY WENT TO URGENT CARE FOR TESTING BECAUSE I AM 22 WEEKS PREGNANT AND THE RAPID ANTIGEN TEST WAS ALSO NEGATIVE, BUT THE PCR CAME OUT POSITIVE. FRIEND TOLD ME AFTERWARDS THAT FLOW FLEX TESTS HAD A BAD REPUTATION, BUT THEY WERE THE ONLY ONES COVERED BY MY INSURANCE (B)(6) WHEN I BOUGHT THEM FOR HOME USE. FDA SAFETY REPORT ID# (B)(4). REFER TO: MW5108021.

Description of Event or Problem · 0

BATCH RECORDS FOR FINAL PRODUCT MANUFACTURING AND QC RECORDS FOR COV1120162 WERE REVIEWED AND NO ABNORMAL ISSUE WAS FOUND IN THE MANUFACTURING PROCESS, TECHNICAL TESTING AND QUALITY CONTROL INSPECTION, AND THE MANUFACTURING PROCESS. THE TEST RESULTS OF RETAINED SAMPLES OF COV1120162 MET THE QC CRITERIA. THE COMPLAINT ISSUE WAS NOT FOUND WITH THE RETAINED CASSETTES. THE ROOT CAUSE IS UNDERTERMINED. SIMILAR ISSUES WILL BE TRACKED AND TRENDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
722585 FLOWFLEX COVID-19 ANTIGEN HOME TEST ANTIGEN DIAGNOSTIC FOR SARS-COV-2, PRODUCT CODE: QKP QKP ACON LABORATORIES, INC. L031-118B5 COV1120162

Patients

Seq Age Sex Outcome Treatment
1 Female Hospitalization